Argos Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2017
Argos Therapeutics, Inc. reported earnings results for the third quarter and nine months ended September 30, 2017. For the quarter, the company reported revenue was $53,000 compared to $147,000 for the same period in 2016.
For the nine months, the company reported revenue was $228,000 compared to $782,000 for the same period in 2016. Net loss for the nine months ended September 30, 2017 was $38.7 million compared to a net loss of $37.7 million for the same period in 2016.